The transition from NAFLD to MASLD and its impact on clinical practice and outcomes.

Lu, Zhenhua; Shao, Weiwei; Song, Jinghai

Lu, Zhenhua; Shao, Weiwei; Song, Jinghai.

Afiliação

Lu Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Shao W; Department of Hepatobiliary Surgery, Beijing Chaoyang Hospital affiliated to Capital Medical University, Beijing 100020, China.
Song J; Department of General Surgery, Department of Hepato-Bilio-Pancreatic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China. Electronic address: jhaisong2003@126.com.

J Hepatol ; 81(4): e155-e156, 2024 Oct.

Article em En | MEDLINE | ID: mdl-38423477

Assuntos

Hepatopatia Gordurosa não Alcoólica; Humanos; Hepatopatia Gordurosa não Alcoólica/complicações; Progressão da Doença

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Limite: Humans Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google